AstraZeneca is conducting a Phase III study titled ‘A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol ...

India: Inhalation therapy remains a cornerstone in the treatment of obstructive, inflammatory, and infectious respiratory ...

Orbia Fluor & Energy Materials’ pharmaceutical business unit has published a new whitepaper about the industry’s ongoing transition to pressurised metered dose inhalers (pMDIs) to low global warming ...

Inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) needed to clear lung surfactant improved ...

The Airsupra inhaler reduces severe asthma attacks by 47%, combining immediate relief with anti-inflammatory action.

The global airway disease treatment market is poised for significant expansion, with a projected increase from USD 2.3 ...

Professor Omar Usmani and Respiratory Effectiveness Group colleagues outline a pragmatic approach to inhaler choice and ...

Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million ...

A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.

Fixed-dose combination inhalers containing both a steroid and a fast-acting beta₂-agonist (FABA) in the same device simplify inhalers regimens and ensure symptomatic relief is accompanied by ...

MediPharm Labs has launched metered dose inhalers in the Canadian Adult Use & Wellness and Medical channels and expects to launch in Australia, the EU and the United Kingdom in Q3 of this year.

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers SmartTrack™ aims to reduce the need for ...